Monika Madaan1, Swati Agrawal2, Manju Puri3, Aruna Nigam4, Harvinder Kaur5, Shubha Sagar Trivedi6. 1. Ex Assistant Professor, Department of Obstetrics and Gynecology, LHMC & SSKH (Lady Hardinge Medical College and Smt Sucheta Kriplani Hospital) , New Delhi, India . 2. Assistant Professor, Department of Obstetrics and Gynecology, LHMC & SSKH , New Delhi, India . 3. Professor, Department of Obstetrics and Gynecology, LHMC & SSKH , New Delhi, India . 4. Ex. Assistant Professor, Department of Obstetrics and Gynecology, LHMC & SSKH , New Delhi, India . 5. GDMO, Department of Obstetrics and Gynecology, LHMC & SSKH , New Delhi, India . 6. Director Professor, Department of Obstetrics and Gynecology, LHMC & SSKH , New Delhi, India .
Abstract
OBJECTIVE: To compare the efficacy and safety profile of low dose vaginal misoprostol with dinoprostone gel for induction of labor in term pregnancies. METHODS: The study was conducted at Lady Hardinge Medical College and Smt Sucheta Kriplani Hospital on 100 pregnant women with term pregnancy after application of inclusion and exclusion criteria. The women were randomized in 2 groups of 50 women each. Group I received misoprostol 25μg at every six hour vaginally for a maximum of five doses for induction of labor; while group II received dinoprostone gel 0.5 mg every six hourly for a maximum of three doses. Maternal outcomes such as mode of delivery and induction delivery interval; and fetal outcomes such as APGAR score and incidence of NICU admission were assessed in both the groups. Statistical analysis was done using student t-test and chi-square test. RESULTS: There was no significant difference in the mean induction to delivery interval in both the groups (14.32±0.13 hours in Group I and 14.92±0.18 hours in Group II, p=0.75), mode of delivery, indication of cesarean section and perinatal outcome. However, significant difference was observed in requirement of oxytocin augmentation in both the groups (32% in Group I and 68% in Group II, p=0.005). CONCLUSION:Vaginal misoprostol in low doses is similar in efficacy and safety to dinoprostone gel for cervical ripening and labor induction in term pregnancy.
RCT Entities:
OBJECTIVE: To compare the efficacy and safety profile of low dose vaginal misoprostol with dinoprostone gel for induction of labor in term pregnancies. METHODS: The study was conducted at Lady Hardinge Medical College and Smt Sucheta Kriplani Hospital on 100 pregnant women with term pregnancy after application of inclusion and exclusion criteria. The women were randomized in 2 groups of 50 women each. Group I received misoprostol 25μg at every six hour vaginally for a maximum of five doses for induction of labor; while group II received dinoprostone gel 0.5 mg every six hourly for a maximum of three doses. Maternal outcomes such as mode of delivery and induction delivery interval; and fetal outcomes such as APGAR score and incidence of NICU admission were assessed in both the groups. Statistical analysis was done using student t-test and chi-square test. RESULTS: There was no significant difference in the mean induction to delivery interval in both the groups (14.32±0.13 hours in Group I and 14.92±0.18 hours in Group II, p=0.75), mode of delivery, indication of cesarean section and perinatal outcome. However, significant difference was observed in requirement of oxytocin augmentation in both the groups (32% in Group I and 68% in Group II, p=0.005). CONCLUSION: Vaginal misoprostol in low doses is similar in efficacy and safety to dinoprostone gel for cervical ripening and labor induction in term pregnancy.
Authors: Cecilia Lyons; Kay Beharry; Yasir Akmal; Frank Attenello; Michael P Nageotte Journal: Prostaglandins Other Lipid Mediat Date: 2003-01 Impact factor: 3.072